Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group
暂无分享,去创建一个
J. Meza | S. Donaldson | A. Pappo | D. Hawkins | W. Meyer | J. Breneman | C. Arndt | A. Hayes-Jordan | R. B. Raney | D. Walterhouse | R. Raney
[1] James R. Anderson,et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] C. Haie-meder,et al. Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience. , 2008, International journal of radiation oncology, biology, physics.
[3] M. Hudson,et al. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H. B. Marsden,et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] James R. Anderson,et al. Rhabdomyosarcoma: many similarities, a few philosophical differences. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. D. de Haan,et al. Quality of life, self‐esteem and worries in young adult survivors of childhood cancer , 2004, Psycho-oncology.
[7] James R. Anderson,et al. Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M. Grootenhuis,et al. Quality of life in young adult survivors of childhood cancer , 2002, Supportive Care in Cancer.
[9] I. Leuschner,et al. Rhabdomyosarcoma of the Urinary Bladder and Vagina: A Clinicopathologic Study With Emphasis on Recurrent Disease: A Report From the Kiel Pediatric Tumor Registry and the German CWS Study , 2001, The American journal of surgical pathology.
[10] James R. Anderson,et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] James R. Anderson,et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? , 2001, Cancer.
[12] L. Diller,et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood , 2001, Cancer.
[13] C. Haie-meder,et al. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S. Qualman,et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. , 1999, Journal of pediatric surgery.
[15] Timothy J. Triche,et al. Intergroup Rhabdomyosarcoma Study: Update for Pathologists , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[16] E. Gehan,et al. The Third Intergroup Rhabdomyosarcoma Study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Nihoul-Fékété,et al. Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[19] S. Donaldson,et al. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. , 1994, Medical and pediatric oncology.
[20] R. Wittes,et al. Methodologic guidelines for reports of clinical trials. , 1985, Cancer treatment reports.